John A. Macoviak MD is a retired heart transplant surgeon trained by Norman E. Shumway MD PhD and John C. Baldwin MD at Stanford, and L. Henry Edmunds MD at the Hospital of the University of Pennsylvania, practiced and taught medical students at Universities in California, Washington DC, and Boston from 1983 to 2002 and at Mayo Clinic in 2008-2009.
John A. Macoviak, MD, MBA, is a reputable medical professional focused on becoming an author and blogger. Known for performing the first heart transplant in Washington, DC. and the world's first Heart Transplant combined with Dr. Hans Sollinger's combined Pancreas Transplant John (J.A.) Macoviak, MD, MBA, has stayed abreast of combined medical transplants, including the first combined heart, kidney, and pancreas transplantation in Europe.
Multiorgan transplantation procedures involving the kidney, heart, and pancreas are not seen very often. This is because it’s rare that diabetic patients present with end-stage renal and cardiac failure at the same time. However, it does happen, as was the case with a 42-year-old male in Europe in 1990.
The man who received the first heart-kidney-pancreas transplant had been dealing with type 1 diabetes since the age of 13. He had been on insulin therapy since first being diagnosed. The disease took a toll on the man’s body, and he began dealing with diabetic nephropathy in 1984. By 1988, he began ambulatory peritoneal dialysis to his advanced renal insufficiency (RI). He had experienced congestive heart failure (CHF) a couple years prior.
On top of his worsening CHF, which ultimately required IV inotropic therapy, the man’s unstable diabetes led to several other degenerative complications, such as exudative retinopathy and autonomous nervous system disorders. The triple-organ procedure was deemed the man’s best chance of survival after an urgent review of his case.
Using the Lower and Shumway technique, the heart was transplanted first. This was followed by the transplantation of the pancreas and the kidney. The three organs quickly began functioning normally after transplanting, and the patient no longer needed insulin therapy for his previous diagnosis of diabetes.

